Financhill
Back

RxSight 10K Form

Sell
6

RXST
RxSight

Last Price:
49.36
Seasonality Move:
12.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RXST News And Ratings

See the #1 stock for the next 7 days that we like better than RXST

RXST Financial Statistics

Sales & Book Value

Annual Sales: $89.08M
Cash Flow: $-5.55M
Price / Cash Flow: 0
Annual Sales: $6.95
Price / Book: 7.1

Profitability

EPS (TTM): -1.01000
Net Income (TTM): $-36.77M
Gross Margin: $53.77M
Return on Equity: -20.02%
Return on Assets: -17.54%

RxSight Earnings Forecast

Key RxSight Financial Ratios

  • The Gross Profit Margin over the past 5 years for RXST is 60.36%.
  • The Selling, General & Administrative Expenses for RXST have been equal to 83.97% of Gross Profit Margin.
  • The Research & Development expenses have been 32.61% of Revenue.
  • The Interest Expense is -6.81% of Operating Income.
  • The Net Earning history of RXST is -54.57% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

RxSight Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: RXST
Website: rxsight.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 14.33
Quick Ratio: 13.2

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 270.66

RXST Technical Analysis vs Fundamental Analysis

Sell
6
RxSight (RXST) is a Sell

Is RxSight a Buy or a Sell?

  • RxSight stock is rated a Sell
    The current RxSight [RXST] share price is $49.26. The Score for RXST is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.